Yeji
FDA approvaloutcome: successconf 1.00

voxzogo — FDA approval

$BMRN · BIOMARIN PHARMACEUTICAL INC
Event date
November 19, 2021
1660 days ago
Sponsor runway
cash-flow +
$2.22B liquid

Evidence

“openFDA ORIG (TYPE 1) approval of VOXZOGO 0.4MG — application NDA214938”
Source ↗

Comparable historical fda approvals· last 5 years · same event type

100% hit rate (10/10)
TickerDrugDateOutcome
$INCYzynyz2026-05-18success
$INCYjakafi xr2026-05-01success
$AXSMauvelity2026-04-30success
$INCYzynyz2026-03-30success
$BIIBspinraza2026-03-27success
$CORTlifyorli2026-03-25success
$RYTMimcivree2026-03-19success
$ASNDyuviwel2026-02-27success
$BMRNpalynziq2026-02-27success
$ETONdesmoda2026-02-25success

Recent insider activity· ±90 days

5 insiders · 0 buys · 7 sells
Tax
2022-02-03
Mueller Brian
EVP, Chief Financial Officer
1,072 @ $87.77$94K
Exercise
2022-01-14
LAWLIS V BRYAN
Director
4,250 @ $37.46$159K
Sell
2022-01-14
LAWLIS V BRYAN
Director
4,250 @ $87.61$372K
Exercise
2022-01-13
BIENAIME JEAN JACQUES
Director
5,000 @ $37.46$187K
Sell
2022-01-13
BIENAIME JEAN JACQUES
Director
5,000 @ $87.86$439K
Sell
2022-01-12
BIENAIME JEAN JACQUES
Director
5,000 @ $89.00$445K
Exercise
2022-01-12
BIENAIME JEAN JACQUES
Director
5,000 @ $37.46$187K
Grant
2022-01-03
Alles Mark J
Director
2,300 @ ——
Small
2021-12-21
BIENAIME JEAN JACQUES
Director
100 @ $89.22$9K
Exercise
2021-12-16
BIENAIME JEAN JACQUES
Director
6,000 @ $37.46$225K
Sell
2021-12-16
BIENAIME JEAN JACQUES
Director
6,000 @ $84.68$508K
Exercise
2021-12-15
BIENAIME JEAN JACQUES
Director
6,000 @ $37.46$225K
Sell
2021-12-15
BIENAIME JEAN JACQUES
Director
6,000 @ $82.71$496K
Gift
2021-12-10
BIENAIME JEAN JACQUES
Director
700 @ ——
Sell
2021-12-01
BIENAIME JEAN JACQUES
Director
1,500 @ $87.22$131K
Sell
2021-10-26
Ajer Jeffrey Robert
EVP, Chief Commercial Officer
2,739 @ $73.60$202K
Exercise
2021-10-20
BIENAIME JEAN JACQUES
Director
1,000 @ $37.46$37K
Small
2021-09-09
BIENAIME JEAN JACQUES
Director
50 @ $78.77$4K
← All catalysts for $BMRN